These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
291 related items for PubMed ID: 18619957
1. Statins suppress MMP2 secretion via inactivation of RhoA/ROCK pathway in pulmonary vascular smooth muscles cells. Li M, Li Z, Sun X. Eur J Pharmacol; 2008 Sep 04; 591(1-3):219-23. PubMed ID: 18619957 [Abstract] [Full Text] [Related]
2. Simvastatin inhibits MMP-9 secretion from human saphenous vein smooth muscle cells by inhibiting the RhoA/ROCK pathway and reducing MMP-9 mRNA levels. Turner NA, O'Regan DJ, Ball SG, Porter KE. FASEB J; 2005 May 04; 19(7):804-6. PubMed ID: 15728660 [Abstract] [Full Text] [Related]
3. Inhibition of cGMP phosphodiesterase 5 suppresses matrix metalloproteinase-2 production in pulmonary artery smooth muscles cells. Sun XZ, Li ZF, Liu Y, Fang P, Li MX. Clin Exp Pharmacol Physiol; 2010 Mar 04; 37(3):362-7. PubMed ID: 19793106 [Abstract] [Full Text] [Related]
4. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells. Itoh Y, Kimoto K, Imaizumi M, Nakatsuka K. Exp Eye Res; 2007 Mar 04; 84(3):464-72. PubMed ID: 17217948 [Abstract] [Full Text] [Related]
5. Inhibitory effects of simvastatin on platelet-derived growth factor signaling in pulmonary artery smooth muscle cells from patients with idiopathic pulmonary arterial hypertension. Ikeda T, Nakamura K, Akagi S, Kusano KF, Matsubara H, Fujio H, Ogawa A, Miura A, Miura D, Oto T, Yamanaka R, Otsuka F, Date H, Ohe T, Ito H. J Cardiovasc Pharmacol; 2010 Jan 04; 55(1):39-48. PubMed ID: 19786891 [Abstract] [Full Text] [Related]
6. Statins normalize vascular lysyl oxidase down-regulation induced by proatherogenic risk factors. Rodríguez C, Alcudia JF, Martínez-González J, Guadall A, Raposo B, Sánchez-Gómez S, Badimon L. Cardiovasc Res; 2009 Aug 01; 83(3):595-603. PubMed ID: 19406911 [Abstract] [Full Text] [Related]
7. Nitric oxide inhibits endothelin-1-induced neonatal cardiomyocyte hypertrophy via a RhoA-ROCK-dependent pathway. Hunter JC, Zeidan A, Javadov S, Kilić A, Rajapurohitam V, Karmazyn M. J Mol Cell Cardiol; 2009 Dec 01; 47(6):810-8. PubMed ID: 19799911 [Abstract] [Full Text] [Related]
8. Upregulation of angiotensin II-AT1 receptors during statin withdrawal in vascular smooth muscle cells. Castejon AM, Zollner E, Tristano AG, Cubeddu LX. J Cardiovasc Pharmacol; 2007 Dec 01; 50(6):708-11. PubMed ID: 18091590 [Abstract] [Full Text] [Related]
9. Statins may ameliorate pulmonary hypertension via RhoA/Rho-kinase signaling pathway. Xing XQ, Gan Y, Wu SJ, Chen P, Zhou R, Xiang XD. Med Hypotheses; 2007 Dec 01; 68(5):1108-13. PubMed ID: 17097823 [Abstract] [Full Text] [Related]
10. Sildenafil prevents change in RhoA expression induced by chronic hypoxia in rat pulmonary artery. Sauzeau V, Rolli-Derkinderen M, Lehoux S, Loirand G, Pacaud P. Circ Res; 2003 Oct 03; 93(7):630-7. PubMed ID: 12946946 [Abstract] [Full Text] [Related]
11. Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages. Luan Z, Chase AJ, Newby AC. Arterioscler Thromb Vasc Biol; 2003 May 01; 23(5):769-75. PubMed ID: 12663370 [Abstract] [Full Text] [Related]
12. Inhibition of smooth muscle cell calcium mobilization and aortic ring contraction by lactone vastatins. Escobales N, Crespo MJ, Altieri PI, Furilla RA. J Hypertens; 1996 Jan 01; 14(1):115-21. PubMed ID: 12013483 [Abstract] [Full Text] [Related]
13. HMG-CoA reductase inhibitors up-regulate anti-aging klotho mRNA via RhoA inactivation in IMCD3 cells. Narumiya H, Sasaki S, Kuwahara N, Irie H, Kusaba T, Kameyama H, Tamagaki K, Hatta T, Takeda K, Matsubara H. Cardiovasc Res; 2004 Nov 01; 64(2):331-6. PubMed ID: 15485693 [Abstract] [Full Text] [Related]
14. Angiotensin II up-regulates the leukemia-associated Rho guanine nucleotide exchange factor (RhoGEF), a regulator of G protein signaling domain-containing RhoGEF, in vascular smooth muscle cells. Ying Z, Jin L, Palmer T, Webb RC. Mol Pharmacol; 2006 Mar 01; 69(3):932-40. PubMed ID: 16354763 [Abstract] [Full Text] [Related]
15. Effects of statin treatment and withdrawal on angiotensin II-induced phosphorylation of p38 MAPK and ERK1/2 in cultured vascular smooth muscle cells. Tristano AG, Castejon AM, Castro A, Cubeddu LX. Biochem Biophys Res Commun; 2007 Feb 02; 353(1):11-7. PubMed ID: 17161379 [Abstract] [Full Text] [Related]
16. Inhibition of cGMP phosphodiesterase 5 suppresses serotonin signalling in pulmonary artery smooth muscles cells. Li M, Sun X, Li Z, Liu Y. Pharmacol Res; 2009 May 02; 59(5):312-8. PubMed ID: 19416631 [Abstract] [Full Text] [Related]
17. Inhibition of the RhoA/Rho-associated, coiled-coil-containing protein kinase-1 pathway is involved in the therapeutic effects of simvastatin on pulmonary arterial hypertension. Liu WH, Xu XH, Luo Q, Zhang HL, Wang Y, Xi QY, Zhao ZH, Liu ZH. Clin Exp Hypertens; 2018 May 02; 40(3):224-230. PubMed ID: 29319354 [Abstract] [Full Text] [Related]
18. Role of RhoA inactivation in reduced cell proliferation of human airway smooth muscle by simvastatin. Takeda N, Kondo M, Ito S, Ito Y, Shimokata K, Kume H. Am J Respir Cell Mol Biol; 2006 Dec 02; 35(6):722-9. PubMed ID: 16858009 [Abstract] [Full Text] [Related]
19. Statins prevent pulsatile stretch-induced proliferation of human saphenous vein smooth muscle cells via inhibition of Rho/Rho-kinase pathway. Kozai T, Eto M, Yang Z, Shimokawa H, Lüscher TF. Cardiovasc Res; 2005 Dec 01; 68(3):475-82. PubMed ID: 16098957 [Abstract] [Full Text] [Related]
20. RhoA activation by hypoxia in pulmonary arterial smooth muscle cells is age and site specific. Bailly K, Ridley AJ, Hall SM, Haworth SG. Circ Res; 2004 May 28; 94(10):1383-91. PubMed ID: 15087418 [Abstract] [Full Text] [Related] Page: [Next] [New Search]